Stephen Michael Kelsey
EVP, CMO, Oncology, Geron Corporation.
Companies
- Revolution Medicines (United States)Officer Feb 12, 2020 to now1
- Jiya Acquisition Corp.Board member Nov 18, 2020 to Nov 18, 20202
- MedivationSVP of New Projects May 15, 2013 to Feb 20, 20143
- Geron CorporationEVP, CMO, Oncology Apr 28, 2009 to May 7, 20134
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Revolution Medicines (United States) RVMD286,307 shares5$52.1M at $182.09Sep 16, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 16, 2026Sold 5,484 shares at $199.30 of Revolution Medicines (United States)5
- Sep 16, 2026Sold 85 shares at $195.01 of Revolution Medicines (United States)5
- Sep 11, 2026Sold 3,270 shares at $205.81 of Revolution Medicines (United States)6
- Sep 11, 2026Sold 4,995 shares at $204.84 of Revolution Medicines (United States)6
- Sep 11, 2026Sold 17,949 shares at $203.87 of Revolution Medicines (United States)6
- Sep 11, 2026Sold 18,869 shares at $203.06 of Revolution Medicines (United States)6
- Sep 11, 2026Sold 21,447 shares at $201.75 of Revolution Medicines (United States)6
- Sep 11, 2026Sold 13,368 shares at $200.78 of Revolution Medicines (United States)6
- Sep 11, 2026Sold 11,833 shares at $200.11 of Revolution Medicines (United States)6
- Sep 11, 2026Sold 800 shares at $198.55 of Revolution Medicines (United States)6
- Sep 11, 2026Exercised options 40,031 shares at $40.74 of Revolution Medicines (United States)6
- Sep 11, 2026Exercised options 52,500 shares at $42.45 of Revolution Medicines (United States)6
- Jun 16, 2026Sold 4,175 shares at $156.12 of Revolution Medicines (United States)7
- Mar 17, 2026Sold 4,302 shares at $99.48 of Revolution Medicines (United States)8
- Mar 1, 2026Granted 21,100 shares of Revolution Medicines (United States)9
- Dec 16, 2025Sold 5,447 shares at $76.82 of Revolution Medicines (United States)10
- Oct 13, 2025Sold 25,000 shares at $48.54 of Revolution Medicines (United States)11
- Oct 13, 2025Exercised options 25,000 shares at $4.73 of Revolution Medicines (United States)11
- Sep 16, 2025Sold 5,367 shares at $45.82 of Revolution Medicines (United States)12
- Sep 15, 2025Sold 1,318 shares at $46.93 of Revolution Medicines (United States)13
- Sep 15, 2025Sold 23,682 shares at $45.92 of Revolution Medicines (United States)13
- Sep 15, 2025Exercised options 25,000 shares at $4.73 of Revolution Medicines (United States)13
- Sep 11, 2025Sold 55,941 shares at $44.48 of Revolution Medicines (United States)13
- Sep 11, 2025Sold 44,059 shares at $43.58 of Revolution Medicines (United States)13
- Sep 11, 2025Exercised options 100,000 shares at $4.73 of Revolution Medicines (United States)13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARJiya Acquisition Corp., Board member
- 3SEC EDGARMedivation, SVP of New Projects
- 4
- 5
- 6SEC EDGARForm 4 filed Sep 15, 2026
- 7SEC EDGARForm 4 filed Jun 18, 2026
- 8SEC EDGARForm 4 filed Mar 19, 2026
- 9SEC EDGARForm 4 filed Mar 3, 2026
- 10SEC EDGARForm 4 filed Dec 18, 2025
- 11SEC EDGARForm 4 filed Oct 15, 2025
- 12SEC EDGARForm 4 filed Sep 18, 2025
- 13SEC EDGARForm 4 filed Sep 15, 2025